logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
12/12/2025
After Swiss parliamentarians proposed a compromise on capital rules for UBS Group, UBS Group's stock price rose by 2.7% to its highest level since 2008.
Latest
1 m ago
India Indigo Airlines: Approval to hire Chief Aviation Consultants Limited for independent expert review and assessment.
2 m ago
Maple Leaf Education (01317.HK) spent 131,500 Hong Kong dollars to repurchase 346,000 shares on December 12th.
2 m ago
Prospects for the domestic weight-loss drug market in 2026: In March next year, Novo Nordisk's blockbuster GLP-1 drug molecule semaglutide will see its core patent expire in China. Industry insiders predict that the supply of GLP-1 drugs in the future will far exceed the previous wave of PD-1 targeted drugs from pharmaceutical companies. With a large number of generic drugs coming to market, a price war for GLP-1 drugs is also expected to start in 2026. According to incomplete statistics, as of now, 8 domestic semaglutide drugs have received market approval, respectively from Huisheng Biology, Chengdu Betta, Shiyao Group, Hangzhou Zhongmei Huadong, Zhuhai Federal, Qilu, Lizhu, and Jiuyuan Genetics. (Yicai)
2 m ago
Changfeng Aerospace: Shareholder Chaoyang Municipal Electric Power Co., Ltd. extended the pledge of 0.7342% of the company's shares.
3 m ago
China COSCO Shipping Corporation (01919.HK) spent 60,860,500 Hong Kong dollars on December 12 to repurchase 4.461 million shares.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.